EUVIMEDOpdag EUVIMED
MetaanalyseSystematische ÜbersichtOpen access

Systematic review with meta‐analysis: Medical therapies for treatment of ulcerative proctitis

Achuthan Aruljothy, Siddharth Singh iD, Neeraj Narula iD, Gordon W Moran iD, Sudheer K Vuyyuru, Malcolm Hogan, Alexa Zayadi, John K MacDonald, Benedicte Caron, Silvio Danese iD, Laurent Peyrin Biroulet iD, Christopher Ma iD and 1 more

Alimentary Pharmacology & Therapeutics · 2023-10 · 58 (8) · 740-762

DOI: 10.1111/apt.17666 ↗

At a glance

Metaanalyse in Alimentary Pharmacology & Therapeutics, published online on 2023-08-17. Written by Achuthan Aruljothy and 12 co-authors. Institution: Department of Medicine, Division of Gastroenterology, Western University, London, Ontario, Canada. Major MEDLINE topics: Colitis, Ulcerative, Proctitis. Cited 22 times so far (Crossref); 73 references. The full text is freely available in PubMed Central. Funded by: NLM NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Ulcerative proctitis (UP) is a common highly symptomatic form of ulcerative colitis that can be difficult to treat.

Aim

To assess the efficacy of medical treatments for UP.

Methods

We searched MEDLINE, EMBASE, and CENTRAL on 23 November 2022 for randomised controlled trials (RCTs) of medical therapy for adults with UP. Primary outcomes included induction and maintenance of clinical remission. Pooled risk ratios (RRs) and 95% confidence intervals (CIs) were calculated for each outcome.

Results

We included 53 RCTs ( n = 4096) including 46 induction studies ( n = 3731) and seven maintenance studies ( n = 365). First‐line therapies included topical 5‐aminosalicylic acid (5‐ASA), conventional corticosteroids, budesonide, and oral 5‐ASA. Therapy for refractory UP included topical tacrolimus and small molecules. Topical 5‐ASA was superior to placebo for induction (RR 2.72, 95% CI 1.94–3.82) and maintenance of remission (RR 2.09, 95% CI 1.26–3.46). Topical corticosteroids were superior to placebo for induction of remission (RR 2.83, 95% CI 1.62–4.92). Topical budesonide was superior to placebo for induction of remission (RR 2.34, 95% CI 1.44–3.81). Combination therapy with topical 5‐ASA and topical corticosteroids was superior to topical monotherapy with either agent. Topical tacrolimus was superior to placebo. Etrasimod was superior to placebo for induction (RR 4.71, 95% CI 1.2–18.49) and maintenance of remission (RR 2.08, 95% CI 1.31–3.32).

Conclusions

Topical 5‐ASA and corticosteroids are effective for active UP. Topical 5‐ASA may be effective for maintenance of remission. Tacrolimus may be effective for induction of remission. Etrasimod may be effective for induction and for maintenance of remission. Trials should include UP to expand the evidence base for this under‐represented population.

Subjects

MeSH terms (MEDLINE)

Colitis, UlcerativeProctitisAdultHumansAdministration, OralAnti-Inflammatory Agents, Non-SteroidalBudesonideMesalamineRemission InductionTacrolimusAcetatesIndoles

Substances

Anti-Inflammatory Agents, Non-SteroidalBudesonideMesalamineTacrolimusetrasimodAcetatesIndoles

Authors and institutions

  • Department of Medicine, Division of Gastroenterology, Western University, London, Ontario, Canada.
  • Division of Gastroenterology, Department of Medicine, University of California San Diego, La Jolla, California, USA.
  • Division of Gastroenterology, McMaster University, Hamilton, Ontario, Canada.
  • National Institute of Health Research Nottingham Biomedical Research Centre, University of Nottingham and Nottingham University Hospitals, Nottingham, UK.
  • Alimentiv, Inc., London, Ontario, Canada.
  • Department of Gastroenterology, University of Lorraine, CHRU-Nancy, Nancy, France.

ORCID profiles: Siddharth Singh, Neeraj Narula, Gordon W Moran, Silvio Danese, Laurent Peyrin Biroulet, Christopher Ma, Vipul Jairath

Funding

  • NLM NIH HHS

Cite

APA

Aruljothy, A., Singh, S., Narula, N., Moran, G. W., Vuyyuru, S. K., Hogan, M., Zayadi, A., MacDonald, J. K., Caron, B., Danese, S., Peyrin Biroulet, L., Ma, C., & Jairath, V. (2023). Systematic review with meta‐analysis: Medical therapies for treatment of ulcerative proctitis. Alimentary Pharmacology & Therapeutics, 58(8), 740-762. https://doi.org/10.1111/apt.17666

Vancouver

Aruljothy A, Singh S, Narula N, Moran GW, Vuyyuru SK, Hogan M, et al. Systematic review with meta‐analysis: Medical therapies for treatment of ulcerative proctitis. Alimentary Pharmacology & Therapeutics. 2023;58(8):740-762. doi:10.1111/apt.17666

BibTeX
@article{Aruljothy2023,
  author = {Aruljothy, Achuthan and Singh, Siddharth and Narula, Neeraj and Moran, Gordon W and Vuyyuru, Sudheer K and Hogan, Malcolm and Zayadi, Alexa and MacDonald, John K and Caron, Benedicte and Danese, Silvio and Peyrin Biroulet, Laurent and Ma, Christopher and Jairath, Vipul},
  title = {Systematic review with meta‐analysis: Medical therapies for treatment of ulcerative proctitis},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2023},
  volume = {58},
  number = {8},
  pages = {740--762},
  doi = {10.1111/apt.17666}
}
Start for free →